CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
Study sponsor: Emergent BioSolutions
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2008-10Actual
Enrollment · participants5Actual
Source updated2026-10-07Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.